PUBLISHER: Grand View Research | PRODUCT CODE: 1630937
PUBLISHER: Grand View Research | PRODUCT CODE: 1630937
The global home care testing market size is estimated to reach USD 17.95 billion by 2030, registering to grow at a CAGR of 9.36% from 2025 to 2030 according to a new report by Grand View Research, Inc. The growth of the market is attributed to factors, such as increasing demand for convenient and accessible healthcare solutions, growing focus on preventative healthcare and wellness, and technological advancements.An increase in technological advancements is another major factor contributing to the market growth. There have been significant advances in diagnostic technologies, such as digital imaging, molecular diagnostics, and lab-on-a-chip systems, which have enabled the development of innovative and effective at-home testing devices. In March 2023, Cue Health, a healthcare technology company, expanded its Cue Care platform with the launch of a suite of at-home diagnostic tests.
The tests are designed to provide individuals with quick and accurate results, allowing them to take control of their health and wellness. The new tests include a range of options, such as tests for COVID-19, influenza, and Respiratory Syncytial Virus (RSV).Furthermore, home care testing has helped to reduce healthcare costs. By enabling patients to conduct their own tests at home, healthcare providers can save on the cost of labor and infrastructure needed to perform testing in a healthcare setting. This can help make healthcare more affordable and accessible for patients, particularly those with chronic conditions requiring frequent testing. In addition, home care testing has increased accessibility for patients in rural or remote areas who may not have easy access to healthcare facilities.
By enabling patients to conduct tests at home, healthcare providers reach patients who might have difficulty accessing healthcare services.The pandemic has highlighted the importance of regular monitoring and early detection of diseases, which has boosted the demand for home care testing kits. Companies have been developing new technologies and solutions to address the growing demand for quick and accurate testing solutions. This has led to the development of a range of new home care testing products, including rapid antigen tests, antibody tests, and PCR tests, which have all been used to help diagnose and monitor COVID-19. In March 2023, Lucira Health received FDA authorization for its over-the-counter (OTC) flu and COVID-19 test. The test enables individuals to test themselves for COVID-19 and the flu at home, without the need for a healthcare provider.